Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Xeris Biopharma Holdings, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 162
- +19 vs. Q3 2024
- Shares held
- 65.6M
- +1.68M (+2.6%) vs. Q3 2024
- Total value
- $222.2M
- +$40.2M (+22.1%) vs. Q3 2024
- New holders
- 31
- 59 more added
- Sold out
- 12
- 33 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XERS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $857.1M |
| Q1 2026 | 239 | $610.3M |
| Q4 2025 | 227 | $792.0M |
| Q3 2025 | 231 | $789.3M |
| Q2 2025 | 201 | $422.9M |
| Q1 2025 | 199 | $480.9M |
| Q4 2024 | 162 | $222.2M |
| Q3 2024 | 144 | $182.2M |
| Q2 2024 | 135 | $136.6M |
| Q1 2024 | 142 | $133.7M |
| Q4 2023 | 120 | $140.8M |
| Q3 2023 | 111 | $102.3M |
| Q2 2023 | 105 | $146.7M |
| Q1 2023 | 92 | $80.6M |
| Q4 2022 | 97 | $71.6M |
| Q3 2022 | 101 | $89.3M |
| Q2 2022 | 103 | $91.3M |
| Q1 2022 | 103 | $129.2M |
| Q4 2021 | 92 | $120.2M |
| Q3 2021 | 71 | $42.9M |
| Q2 2021 | 94 | $114.9M |
| Q1 2021 | 103 | $149.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Xeris Biopharma Holdings, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MetLife Investment Management | 87,432 | $296.4K | 0.00% | +28,224+47.7% | Added |
| Creative Planning | 91,267 | $309.4K | 0.00% | +47,088+106.6% | Added |
| SG Americas Securities, LLC | 94,671 | $321.0K | 0.00% | +34,469+57.3% | Added |
| BNP Paribas Arbitrage, SA | 100,012 | $339.0K | 0.00% | +100,012 | New |
| Schonfeld Strategic Advisors LLC | 103,000 | $349.2K | 0.00% | −69,327−40.2% | Reduced |
| Susquehanna International Group, LLP | 107,344 | $363.9K | 0.00% | +27,429+34.3% | Added |
| Principal Financial Group Inc | 113,217 | $383.8K | 0.00% | +10,748+10.5% | Added |
| Roundview Capital LLC | 120,000 | $406.8K | 0.03% | +120,000 | New |
| Globeflex Capital L P | 125,210 | $424.5K | 0.04% | +125,210 | New |
| Deutsche Bank AG | 127,600 | $432.6K | 0.00% | +48,068+60.4% | Added |
| Mackenzie Financial Corp | 129,952 | $440.5K | 0.00% | +106,153+446.0% | Added |
| Alliancebernstein L.P. | 131,570 | $446.0K | 0.00% | −16,150−10.9% | Reduced |
| Citigroup Inc | 132,446 | $449.0K | 0.00% | +13,019+10.9% | Added |
| Fairfax Financial Holdings LtdSuperinvestorFairfax Financial | 139,687 | $472.1K | 0.03% | −31,250−18.3% | Reduced |
| Legato Capital Management LLC | 142,164 | $481.9K | 0.06% | +142,164 | New |
| Thompson Siegel & Walmsley LLC | 152,784 | $518.0K | 0.01% | −20,000−11.6% | Reduced |
| Alpine Global Management, LLC | 160,000 | $542.4K | 0.16% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 170,482 | $578.0K | 0.00% | +9,506+5.9% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 171,332 | $580.8K | 0.00% | +88,224+106.2% | Added |
| Diversified Trust Co | 175,739 | $595.8K | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 180,964 | $613.5K | 0.00% | +7,408+4.3% | Added |
| Stonepine Capital Management, LLC | 182,317 | $618.1K | 0.50% | +182,317 | New |
| Commonwealth Equity Services, LLC | 187,443 | $635.0K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 190,255 | $645.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 209,923 | $711.6K | 0.00% | −7,166−3.3% | Reduced |
| Lazard Asset Management LLC | 216,693 | $734.0K | 0.00% | −161,646−42.7% | Reduced |
| EAM Investors, LLC | 222,377 | $753.9K | 0.11% | +222,377 | New |
| Legal & General Group Plc | 230,467 | $781.3K | 0.00% | +19,624+9.3% | Added |
| IHT Wealth Management, LLC | 270,160 | $915.9K | 0.03% | −6,725−2.4% | Reduced |
| Tudor Investment Corp Et Al | 305,186 | $1.03M | 0.01% | −202,171−39.8% | Reduced |
| Jane Street Group, LLC | 306,245 | $1.04M | 0.00% | −12,515−3.9% | Reduced |
| Bank of New York Mellon Corp | 322,375 | $1.09M | 0.00% | −6,873−2.1% | Reduced |
| Barclays PLC | 347,642 | $1.18M | 0.00% | +23,170+7.1% | Added |
| Charles Schwab Investment Management Inc | 402,872 | $1.37M | 0.00% | −489−0.1% | Reduced |
| Redmile Group, LLC | 451,099 | $1.53M | 0.11% | −595,488−56.9% | Reduced |
| Qube Research & Technologies Ltd | 459,608 | $1.56M | 0.00% | +218,037+90.3% | Added |
| Wellington Management Group LLP | 465,112 | $1.58M | 0.00% | −6,532−1.4% | Reduced |
| Essex Investment Management Co LLC | 474,955 | $1.61M | 0.29% | +474,955 | New |
| Parkman Healthcare Partners LLC | 578,511 | $1.96M | 0.26% | +476,118+465.0% | Added |
| Driehaus Capital Management LLC | 594,015 | $2.01M | 0.02% | +594,015 | New |
| Kennedy Capital Management, Inc. | 666,095 | $2.26M | 0.05% | +61,238+10.1% | Added |
| CenterBook Partners LP | 690,077 | $2.34M | 0.14% | −2,791,929−80.2% | Reduced |
| Citadel Advisors LLC | 833,328 | $2.82M | 0.00% | +833,328 | New |
| AQR Capital Management LLC | 834,940 | $2.83M | 0.00% | −233,176−21.8% | Reduced |
| Bank of America Corp | 991,657 | $3.36M | 0.00% | −17,544−1.7% | Reduced |
| Knott David M Jr | 1,000,000 | $3.39M | 1.23% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,043,441 | $3.54M | 0.00% | +651,481+166.2% | Added |
| Northern Trust Corp | 1,196,381 | $4.06M | 0.00% | +38,155+3.3% | Added |
| D. E. Shaw & Co., Inc. | 1,363,452 | $4.62M | 0.01% | +378,437+38.4% | Added |
| Goldman Sachs Group Inc | 1,590,579 | $5.39M | 0.00% | +754,137+90.2% | Added |
| UBS Group AG | 1,734,491 | $5.88M | 0.00% | +1,451,239+512.3% | Added |
| Nuveen Asset Management, LLC | 1,903,442 | $6.45M | 0.00% | +228,380+13.6% | Added |
| Millennium Management LLC | 1,948,552 | $6.61M | 0.01% | +502,853+34.8% | Added |
| Caxton Corp | 2,015,157 | $6.83M | 41.06% | −3,098,191−60.6% | Reduced |
| Renaissance Technologies LLC | 2,098,840 | $7.12M | 0.01% | +500,120+31.3% | Added |
| AIGH Capital Management LLC | 2,574,846 | $8.73M | 3.29% | +389,192+17.8% | Added |
| Morgan Stanley | 2,877,516 | $9.75M | 0.00% | +523,208+22.2% | Added |
| Rosalind Advisors, Inc. | 3,104,995 | $10.5M | 5.67% | 00.0% | Unchanged |
| State Street Corp | 3,341,874 | $11.3M | 0.00% | +137,156+4.3% | Added |
| Geode Capital Management, LLC | 3,351,426 | $11.4M | 0.00% | +17,956+0.5% | Added |
| Vanguard Group Inc | 7,899,063 | $26.8M | 0.00% | +133,738+1.7% | Added |
| BlackRock, Inc. | 10,821,128 | $36.7M | 0.00% | +87,097+0.8% | Added |
| Walleye Capital LLC | 0 | $0 | 0.00% | −1,121,738−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −84,740−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −34,710−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −15,425−100.0% | Sold out |
| Stoneridge Investment Partners LLC | 0 | $0 | 0.00% | −15,028−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,890−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −1,015−100.0% | Sold out |
| Spectrum Wealth Counsel, LLC | 0 | $0 | 0.00% | −834−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −611−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −607−100.0% | Sold out |
| American Capital Advisory, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |